Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA in Knee Osteoarthritis
NCT06000410Phase 3Completed
- Sponsor
- Organogenesis
- Start
- Sep 2023
- Primary completion
- Aug 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing ASA with Placebo (2 arms). Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Pain Scale at 26 weeks. Started Sep 2023; status: completed.
02
Drugs
amniotic suspension allograft
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06000410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06000410.